MA26920A1 - Ligands des recepteurs de melanocortine. - Google Patents

Ligands des recepteurs de melanocortine.

Info

Publication number
MA26920A1
MA26920A1 MA26976A MA26976A MA26920A1 MA 26920 A1 MA26920 A1 MA 26920A1 MA 26976 A MA26976 A MA 26976A MA 26976 A MA26976 A MA 26976A MA 26920 A1 MA26920 A1 MA 26920A1
Authority
MA
Morocco
Prior art keywords
ligands
melanocortine
receptors
melanocortine receptors
het
Prior art date
Application number
MA26976A
Other languages
English (en)
Inventor
Philip Albert Carpino
Bridget Mccarthy Cole
Bradley Paul Morgan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA26920A1 publication Critical patent/MA26920A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MA26976A 2000-06-28 2002-12-24 Ligands des recepteurs de melanocortine. MA26920A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21461600P 2000-06-28 2000-06-28

Publications (1)

Publication Number Publication Date
MA26920A1 true MA26920A1 (fr) 2004-12-20

Family

ID=22799775

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26976A MA26920A1 (fr) 2000-06-28 2002-12-24 Ligands des recepteurs de melanocortine.

Country Status (26)

Country Link
US (1) US20020072604A1 (fr)
EP (1) EP1294719A1 (fr)
JP (1) JP2004501917A (fr)
KR (1) KR20030017571A (fr)
CN (1) CN1440406A (fr)
AP (1) AP2001002196A0 (fr)
AR (1) AR030301A1 (fr)
AU (1) AU2001260548A1 (fr)
BG (1) BG107268A (fr)
BR (1) BR0111567A (fr)
CA (1) CA2412563A1 (fr)
EA (1) EA200201119A1 (fr)
EC (1) ECSP024404A (fr)
IL (1) IL152781A0 (fr)
IS (1) IS6617A (fr)
MA (1) MA26920A1 (fr)
MX (1) MXPA03000063A (fr)
NO (1) NO20026280L (fr)
OA (1) OA12296A (fr)
PA (1) PA8521501A1 (fr)
PE (1) PE20020208A1 (fr)
PL (1) PL360855A1 (fr)
TN (1) TNSN01097A1 (fr)
UY (1) UY26804A1 (fr)
WO (1) WO2002000654A1 (fr)
ZA (1) ZA200210277B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001264977B2 (en) * 2000-05-30 2005-04-14 Merck & Co., Inc. Melanocortin receptor agonists
CA2438272A1 (fr) 2001-03-02 2002-10-10 John Macor Composes utiles comme modulateurs des recepteurs de la melanocortine et compositions pharmaceutiques renfermant ceux-ci
US6911447B2 (en) * 2001-04-25 2005-06-28 The Procter & Gamble Company Melanocortin receptor ligands
US7456184B2 (en) * 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
WO2003013571A1 (fr) 2001-08-10 2003-02-20 Palatin Technologies, Inc. Peptidomimetiques de metallopeptides biologiquement actifs
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US7732451B2 (en) * 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
US7655658B2 (en) * 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
US7354923B2 (en) * 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
CA2468015A1 (fr) 2001-11-27 2003-06-05 Merck & Co., Inc. Composes de 2-aminoquinoline
US7026335B2 (en) 2002-04-30 2006-04-11 The Procter & Gamble Co. Melanocortin receptor ligands
TW200504033A (en) 2002-10-23 2005-02-01 Procter & Gamble Melanocortin receptor ligands
EP1595867A4 (fr) 2003-02-10 2008-05-21 Banyu Pharma Co Ltd Antagonistes des recepteurs de l'hormone concentrant la melanine contenant des derives de piperidine en tant que principe actif
US7968548B2 (en) 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7795267B2 (en) 2003-08-29 2010-09-14 Takeda Pharmaceutical Company Limited Bicyclic piperazine compound having TGR23 antagonistic activity
JP2005306839A (ja) * 2003-08-29 2005-11-04 Takeda Chem Ind Ltd 二環性ピペラジン化合物およびその用途
DE602005026380D1 (de) * 2004-04-08 2011-03-31 Astellas Pharma Inc Verbindung ws727713
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
ES2877349T3 (es) * 2005-07-08 2021-11-16 Ipsen Pharma Ligandos de los receptores de la melanocortina
CA2617546C (fr) 2005-08-03 2014-07-15 Boehringer Ingelheim International Gmbh Utilisation de la flibanserine dans le traitement de l'obesite
EP1945214A1 (fr) 2005-10-29 2008-07-23 Boehringer Ingelheim International GmbH Derives de benzimidazolone utiles pour le traitement des troubles premenstruels et d'autres troubles sexuels chez la femme
PE20080145A1 (es) 2006-03-21 2008-02-11 Janssen Pharmaceutica Nv Tetrahidro-pirimidoazepinas como moduladores de trpv1
JP2009541443A (ja) 2006-06-30 2009-11-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 尿失禁及び関連疾患の治療のためのフリバンセリン
EP2039695A4 (fr) 2006-07-11 2010-09-15 Takeda Pharmaceutical Composé hétérocyclique bicycique et son utilisation
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
CA2660476C (fr) 2006-08-14 2015-11-17 Boehringer Ingelheim International Gmbh Formulations de flibanserine et leur procede de fabrication
JP5220746B2 (ja) 2006-08-25 2013-06-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 制御放出システム及びその製造方法
RU2450017C2 (ru) 2007-05-25 2012-05-10 Ипсен Фарма С.А.С. Лиганды меланокортиновых рецепторов, модифицированные гидантоином
CL2008002693A1 (es) 2007-09-12 2009-10-16 Boehringer Ingelheim Int Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
US8288397B2 (en) 2007-12-17 2012-10-16 Janssen Pharmaceutica Nv Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1076649A4 (fr) * 1998-04-28 2010-06-02 Trega Biosciences Inc Composes a base d'isoquinoline tenant lieu de ligands de recepteurs de melanocortine et procedes d'utilisation
EP1085869A4 (fr) * 1998-06-11 2001-10-04 Merck & Co Inc Derives de spiropiperidine en tant qu'agonistes des recepteurs de la melanocortine
WO2000074679A1 (fr) * 1999-06-04 2000-12-14 Merck & Co., Inc. Piperidines substituees en tant qu'agonistes du recepteur de melanocortine-4

Also Published As

Publication number Publication date
PL360855A1 (en) 2004-09-20
WO2002000654A1 (fr) 2002-01-03
EA200201119A1 (ru) 2003-06-26
OA12296A (en) 2006-05-12
NO20026280D0 (no) 2002-12-30
EP1294719A1 (fr) 2003-03-26
MXPA03000063A (es) 2003-09-25
CA2412563A1 (fr) 2002-01-03
KR20030017571A (ko) 2003-03-03
AU2001260548A1 (en) 2002-01-08
AP2001002196A0 (en) 2002-12-21
NO20026280L (no) 2002-12-30
ZA200210277B (en) 2003-12-19
BG107268A (en) 2003-06-30
BR0111567A (pt) 2003-05-06
PA8521501A1 (es) 2002-10-24
UY26804A1 (es) 2002-01-31
IL152781A0 (en) 2003-06-24
CN1440406A (zh) 2003-09-03
AR030301A1 (es) 2003-08-20
US20020072604A1 (en) 2002-06-13
TNSN01097A1 (fr) 2005-11-10
ECSP024404A (es) 2003-02-06
IS6617A (is) 2002-11-14
PE20020208A1 (es) 2002-03-13
JP2004501917A (ja) 2004-01-22

Similar Documents

Publication Publication Date Title
MA26920A1 (fr) Ligands des recepteurs de melanocortine.
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
NO20022318L (no) Nye forbindelser
BR0115436A (pt) Compostos de piperazinilpirazina atuando como antagonistas do receptor 5ht-2 de serotonina
CY1106424T1 (el) Παραγωγα ν-φαινυλ-πυρρολ γουανιδινης ως συνδετες υποδοχεις μελανοκορτινης
NO20021358D0 (no) Alkylendiamin-substituerte heterocykler
EA200700047A1 (ru) Новые алкильные производные в качестве метаботропных рецепторов глутамата
NO962742D0 (no) Diazabicykliske neurokinin-antagonister
BG108495A (en) 5-ht receptor ligands and uses thereof
ATE524184T1 (de) 2,4-pyrimidindiamin-verbindungen und ihre verwendungszwecke
ATE302770T1 (de) Benzimidazolverbindungen die nociceptinrezeptoraffinität haben
DE60129154D1 (de) Neuartige verbindungen
NO20015413L (no) Anvendelse av dopamin-D3-reseptor-ligander for fremstilling av medikamenter for behandling av nyrefunksjonsforstyrrelser
EA200301143A1 (ru) Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
NO20072060L (no) 2-acylaminotiazolderivater
DE60221813D1 (de) Thiazolopyrimidinderivate und deren verwendung als antagonisten des cx3cr1 rezeptors
MXPA04003544A (es) Benzotriazepinas como ligandos del receptor de gastrina y colecistocinina.
AP9701075A0 (en) Spirocyclic dopamine receptor subtype ligands.
ATE486078T1 (de) 5,6-disubstituierte oxadiazolopyrazine und thiadiazolopyrazine als liganden des cxc- chemokinrezeptors
ATE298742T1 (de) Zykloalkenylsulfonamidderivate
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
DOP2001000174A (es) Ligandos para receptores de melanocortina
BR0317363A (pt) Antagonista de npy-5
ATE275551T1 (de) Halogenpyrimidine
SV2002000513A (es) Ligandos para receptores de melanocortina ref.pc10861abtc/bb